Showing 1,601 - 1,620 results of 100,125 for search '(( 5 ((((nm decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 12 men decrease ))', query time: 1.27s Refine Results
  1. 1601

    Fluorescence of 5-Arylvinyl-5′-Methyl-2,2′-Bipyridyl Ligands and Their Zinc Complexes by Ali H. Younes (1589731)

    Published 2009
    “…The photophysical properties of 5-arylvinyl-5′-methyl-2,2′-bipyridyls (AVMBs, <b>1</b>−<b>9</b>, <b>11</b>) and their zinc complexes were studied. …”
  2. 1602
  3. 1603

    Strain-dependent alterations of fertility parameters in male offspring exposed in utero to DEHP. by Ludwig Stenz (779897)

    Published 2019
    “…Compared with C57.CTL.F1, AGD, sperm concentration and VCL were decreased in C57.D300.F1 (p <7*10<sup>−5</sup>, p <0.05, p <0.02, respectively), AGD (p < 0.002), testes weight (p <0.008), VAP (p <0.008), VSL (p <0.008) and VCL (p <0.003) were decreased in C57.D300.F2, and VAP (p <1*10<sup>−3</sup>), VSL (p <1*10<sup>−3</sup>) and VSL (p <0.004) were decreased in C57.D300.F3. …”
  4. 1604
  5. 1605
  6. 1606
  7. 1607

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  8. 1608

    Genetic resistance to DEHP-induced transgenerational endocrine disruption by Ludwig Stenz (779897)

    Published 2019
    “…A DEHP-susceptibility allele in C57BL/6J contained five SNPs (rs28279710, rs32977910, rs46648903, rs46677594 and rs48287999) affecting SHP and six genes (<i>Svs2</i>, <i>Svs3b</i>, <i>Svs4</i>, <i>Svs3a</i>, <i>Svs6</i> and <i>Svs5)</i> epigenetically silenced by DEHP. …”
  9. 1609

    Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

    Published 2017
    “…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”
  10. 1610
  11. 1611
  12. 1612
  13. 1613
  14. 1614
  15. 1615
  16. 1616
  17. 1617
  18. 1618
  19. 1619
  20. 1620